Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 17 | 2022 | 366 | 3.540 |
Why?
|
| Osteoarthritis, Hip | 7 | 2019 | 107 | 2.050 |
Why?
|
| Knee Joint | 12 | 2022 | 746 | 1.920 |
Why?
|
| Vibration | 8 | 2018 | 30 | 1.810 |
Why?
|
| Shoes | 6 | 2019 | 33 | 1.590 |
Why?
|
| Gait | 13 | 2019 | 412 | 1.450 |
Why?
|
| Weight-Bearing | 12 | 2018 | 159 | 1.340 |
Why?
|
| Pain | 8 | 2022 | 405 | 1.260 |
Why?
|
| Muscle Strength | 5 | 2016 | 136 | 1.260 |
Why?
|
| Osteoarthritis | 7 | 2018 | 328 | 1.180 |
Why?
|
| Pain Measurement | 6 | 2018 | 472 | 0.900 |
Why?
|
| Proprioception | 3 | 2014 | 21 | 0.860 |
Why?
|
| Walking | 5 | 2019 | 259 | 0.810 |
Why?
|
| Leg | 3 | 2008 | 52 | 0.790 |
Why?
|
| Biomechanical Phenomena | 11 | 2019 | 645 | 0.720 |
Why?
|
| Rheumatology | 4 | 2022 | 85 | 0.690 |
Why?
|
| Orthotic Devices | 3 | 2010 | 24 | 0.660 |
Why?
|
| Middle Aged | 24 | 2019 | 9250 | 0.630 |
Why?
|
| Hyperalgesia | 1 | 2018 | 39 | 0.590 |
Why?
|
| Female | 30 | 2022 | 15704 | 0.580 |
Why?
|
| Pain Management | 3 | 2010 | 147 | 0.560 |
Why?
|
| Sensation | 1 | 2016 | 11 | 0.550 |
Why?
|
| Somatosensory Disorders | 2 | 2018 | 11 | 0.540 |
Why?
|
| Male | 25 | 2019 | 15269 | 0.530 |
Why?
|
| Humans | 38 | 2022 | 28395 | 0.520 |
Why?
|
| Joint Instability | 2 | 2016 | 394 | 0.490 |
Why?
|
| Disease Progression | 7 | 2018 | 717 | 0.490 |
Why?
|
| Exercise Therapy | 4 | 2022 | 98 | 0.480 |
Why?
|
| Foot Orthoses | 1 | 2013 | 12 | 0.420 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2020 | 263 | 0.420 |
Why?
|
| Aged | 15 | 2019 | 9256 | 0.420 |
Why?
|
| Touch | 2 | 2008 | 9 | 0.370 |
Why?
|
| Range of Motion, Articular | 5 | 2018 | 704 | 0.370 |
Why?
|
| Bone Density | 1 | 2011 | 143 | 0.360 |
Why?
|
| Joints | 2 | 2008 | 69 | 0.350 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 86 | 0.350 |
Why?
|
| Sensory Thresholds | 4 | 2012 | 23 | 0.340 |
Why?
|
| Pressure | 3 | 2019 | 64 | 0.290 |
Why?
|
| Foot | 2 | 2016 | 44 | 0.250 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 985 | 0.240 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2010 | 192 | 0.230 |
Why?
|
| Musculoskeletal Development | 1 | 2003 | 1 | 0.220 |
Why?
|
| Quadriceps Muscle | 2 | 2016 | 32 | 0.220 |
Why?
|
| Knee | 2 | 2016 | 45 | 0.210 |
Why?
|
| Radiography | 2 | 2018 | 639 | 0.210 |
Why?
|
| Hip Joint | 3 | 2019 | 545 | 0.210 |
Why?
|
| Pilot Projects | 4 | 2017 | 439 | 0.210 |
Why?
|
| Rheumatologists | 2 | 2020 | 15 | 0.200 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 94 | 0.190 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2003 | 138 | 0.190 |
Why?
|
| Adult | 12 | 2019 | 8097 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 192 | 0.180 |
Why?
|
| Feedback, Sensory | 1 | 2019 | 7 | 0.160 |
Why?
|
| Smartphone | 1 | 2019 | 17 | 0.160 |
Why?
|
| Internship and Residency | 1 | 2022 | 219 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 932 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 821 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2022 | 1926 | 0.150 |
Why?
|
| Absorptiometry, Photon | 2 | 2022 | 81 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 125 | 0.140 |
Why?
|
| Fibromyalgia | 1 | 2017 | 30 | 0.130 |
Why?
|
| Phototherapy | 1 | 2017 | 36 | 0.130 |
Why?
|
| Touch Perception | 1 | 2016 | 3 | 0.130 |
Why?
|
| Mechanical Phenomena | 1 | 2016 | 25 | 0.130 |
Why?
|
| Feedback | 1 | 2016 | 33 | 0.130 |
Why?
|
| Auditory Perception | 1 | 2016 | 43 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2002 | 625 | 0.120 |
Why?
|
| Risk Factors | 5 | 2016 | 2408 | 0.120 |
Why?
|
| Accidental Falls | 1 | 2016 | 113 | 0.120 |
Why?
|
| Aging | 1 | 2003 | 1549 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 506 | 0.110 |
Why?
|
| Incidence | 1 | 2016 | 773 | 0.110 |
Why?
|
| Sensation Disorders | 1 | 2012 | 11 | 0.100 |
Why?
|
| Quality of Life | 2 | 2022 | 658 | 0.090 |
Why?
|
| Perception | 1 | 2012 | 78 | 0.090 |
Why?
|
| Braces | 1 | 2010 | 23 | 0.090 |
Why?
|
| Demography | 1 | 2010 | 73 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2012 | 289 | 0.080 |
Why?
|
| Menisci, Tibial | 1 | 2012 | 177 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 326 | 0.080 |
Why?
|
| Income | 1 | 2010 | 77 | 0.080 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2012 | 196 | 0.080 |
Why?
|
| Tendon Injuries | 1 | 2012 | 212 | 0.080 |
Why?
|
| Femoracetabular Impingement | 1 | 2016 | 369 | 0.080 |
Why?
|
| Extremities | 1 | 2008 | 28 | 0.080 |
Why?
|
| Health Status | 1 | 2010 | 224 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2012 | 312 | 0.080 |
Why?
|
| Exercise | 1 | 2012 | 473 | 0.070 |
Why?
|
| Body Height | 1 | 2006 | 36 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3615 | 0.070 |
Why?
|
| Body Weight | 1 | 2006 | 144 | 0.060 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2005 | 3 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 4851 | 0.060 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 17 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2006 | 432 | 0.060 |
Why?
|
| Methotrexate | 1 | 2005 | 36 | 0.060 |
Why?
|
| Lung | 1 | 2005 | 170 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 465 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 27 | 0.050 |
Why?
|
| Etanercept | 1 | 2002 | 21 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2022 | 30 | 0.050 |
Why?
|
| Teaching | 1 | 2022 | 62 | 0.050 |
Why?
|
| Physical Examination | 1 | 2022 | 118 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 160 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2022 | 249 | 0.040 |
Why?
|
| Rotation | 1 | 2019 | 137 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 41 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 152 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 102 | 0.040 |
Why?
|
| Reoperation | 1 | 2002 | 917 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 2069 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 492 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2017 | 21 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 110 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2003 | 931 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 733 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 231 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 298 | 0.030 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2012 | 18 | 0.030 |
Why?
|
| Weight Lifting | 1 | 2012 | 9 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1490 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2012 | 39 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1384 | 0.020 |
Why?
|
| Denmark | 1 | 2012 | 10 | 0.020 |
Why?
|
| Sweden | 1 | 2012 | 9 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 146 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 251 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 1804 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2010 | 13 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 593 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 81 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 676 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 308 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 298 | 0.020 |
Why?
|
| Arthroscopy | 1 | 2016 | 1086 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 351 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 117 | 0.010 |
Why?
|